451 related articles for article (PubMed ID: 26884713)
21. NPM1 Mutant Mediated PML Delocalization and Stabilization Enhances Autophagy and Cell Survival in Leukemic Cells.
Zou Q; Tan S; Yang Z; Zhan Q; Jin H; Xian J; Zhang S; Yang L; Wang L; Zhang L
Theranostics; 2017; 7(8):2289-2304. PubMed ID: 28740552
[TBL] [Abstract][Full Text] [Related]
22. NPM1 mutant maintains ULK1 protein stability via TRAF6-dependent ubiquitination to promote autophagic cell survival in leukemia.
Tang Y; Tao Y; Wang L; Yang L; Jing Y; Jiang X; Lei L; Yang Z; Wang X; Peng M; Xiao Q; Ren J; Zhang L
FASEB J; 2021 Feb; 35(2):e21192. PubMed ID: 33201521
[TBL] [Abstract][Full Text] [Related]
23. Nicotine enhances invasion and metastasis of human colorectal cancer cells through the nicotinic acetylcholine receptor downstream p38 MAPK signaling pathway.
Xiang T; Fei R; Wang Z; Shen Z; Qian J; Chen W
Oncol Rep; 2016 Jan; 35(1):205-10. PubMed ID: 26530054
[TBL] [Abstract][Full Text] [Related]
24. Nucleophosmin Mutations Induce Chemosensitivity in THP-1 Leukemia Cells by Suppressing NF-κB Activity and Regulating Bax/Bcl-2 Expression.
Zhang S; Qin F; Yang L; Xian J; Zou Q; Jin H; Wang L; Zhang L
J Cancer; 2016; 7(15):2270-2279. PubMed ID: 27994664
[No Abstract] [Full Text] [Related]
25. Nucleophosmin 1: from its pathogenic role to a tantalizing therapeutic target in acute myeloid leukemia.
Shi Y; Xue Y; Wang C; Yu L
Hematology; 2022 Dec; 27(1):609-619. PubMed ID: 35621728
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM
J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279
[TBL] [Abstract][Full Text] [Related]
27. Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): comparison with WT1 gene expression.
Barragan E; Pajuelo JC; Ballester S; Fuster O; Cervera J; Moscardo F; Senent L; Such E; Sanz MA; Bolufer P
Clin Chim Acta; 2008 Sep; 395(1-2):120-3. PubMed ID: 18590714
[TBL] [Abstract][Full Text] [Related]
28. Tension Force Downregulates Matrix Metalloproteinase Expression and Upregulates the Expression of Their Inhibitors through MAPK Signaling Pathways in MC3T3-E1 cells.
Karasawa Y; Tanaka H; Nakai K; Tanabe N; Kawato T; Maeno M; Shimizu N
Int J Med Sci; 2015; 12(11):905-13. PubMed ID: 26640410
[TBL] [Abstract][Full Text] [Related]
29. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
[TBL] [Abstract][Full Text] [Related]
30. Development of a flow cytometric method to detect the presence of mutated nucleophosmin 1 in acute myeloid leukemia.
Du Pisani LA; Shires K
Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):106-14. PubMed ID: 26183674
[TBL] [Abstract][Full Text] [Related]
31. Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway.
Zhang Y; Chen HX; Zhou SY; Wang SX; Zheng K; Xu DD; Liu YT; Wang XY; Wang X; Yan HZ; Zhang L; Liu QY; Chen WQ; Wang YF
Mol Cancer; 2015 Mar; 14():56. PubMed ID: 25890196
[TBL] [Abstract][Full Text] [Related]
32. New insights into the biology of acute myeloid leukemia with mutated NPM1.
Brunetti L; Gundry MC; Goodell MA
Int J Hematol; 2019 Aug; 110(2):150-160. PubMed ID: 30632059
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of EMT-related gene VCAN by NPM1 mutant-driven TGF-β/cPML signalling promotes leukemia cell invasion.
Yang L; Wang L; Yang Z; Jin H; Zou Q; Zhan Q; Tang Y; Tao Y; Lei L; Jing Y; Jiang X; Zhang L
J Cancer; 2019; 10(26):6570-6583. PubMed ID: 31777586
[TBL] [Abstract][Full Text] [Related]
34. Mutant NPM1 maintains RASGRP3 protein stability via interaction with MID1 to promote acute myeloid leukemia cell proliferation and autophagy.
Wang Y; Pan C; Zhang X; Zhao A; Dong Y
J Leukoc Biol; 2023 May; 113(5):504-517. PubMed ID: 36826998
[TBL] [Abstract][Full Text] [Related]
35. The effect of small molecule inhibitor NSC348884 on nucleophosmin 1-mutated acute myeloid leukemia cells.
Zhu JF; Han LL; Ma Y; Wang YX; Zhang F
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9145-9151. PubMed ID: 37843328
[TBL] [Abstract][Full Text] [Related]
36. [Research on NPM1 gene mutations in acute myeloid leukemia].
Chen HY; Lu QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):258-62. PubMed ID: 23484732
[TBL] [Abstract][Full Text] [Related]
37. Curcumin induces apoptosis and suppresses invasion through MAPK and MMP signaling in human monocytic leukemia SHI-1 cells.
Zhu GH; Dai HP; Shen Q; Ji O; Zhang Q; Zhai YL
Pharm Biol; 2016 Aug; 54(8):1303-11. PubMed ID: 26134921
[TBL] [Abstract][Full Text] [Related]
38. Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways.
Chang MC; Chen CA; Chen PJ; Chiang YC; Chen YL; Mao TL; Lin HW; Lin Chiang WH; Cheng WF
Biochem J; 2012 Mar; 442(2):293-302. PubMed ID: 21999204
[TBL] [Abstract][Full Text] [Related]
39. A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1).
Liso A; Castiglione F; Cappuccio A; Stracci F; Schlenk RF; Amadori S; Thiede C; Schnittger S; Valk PJ; Döhner K; Martelli MF; Schaich M; Krauter J; Ganser A; Martelli MP; Bolli N; Löwenberg B; Haferlach T; Ehninger G; Mandelli F; Döhner H; Michor F; Falini B
Haematologica; 2008 Aug; 93(8):1219-26. PubMed ID: 18603563
[TBL] [Abstract][Full Text] [Related]
40. Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma.
Aroui S; Aouey B; Chtourou Y; Meunier AC; Fetoui H; Kenani A
Chem Biol Interact; 2016 Jan; 244():195-203. PubMed ID: 26721195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
